What does Arthur Franken invest in?

Arthur Franken invests in Biotech, Digital Health, Medical Devices.

Where did Arthur Franken go to school?

Arthur Franken studied at Leiden University (MSc, Biopharmaceutical Sciences); Lingecollege (VWO-B).

Arthur Franken

Investor

General Partner - Healthtech/Therapeutics Venture&Growth at Gilde Healthcare

The Netherlands

About

Arthur Franken joined Gilde Healthcare in 2001 and helped launch the Venture&Growth strategy, overseeing investments in biopharmaceuticals, medtech, diagnostics, and digital health. He was previously a Research Fellow at the Leiden/Amsterdam Centre for Drug Research and TNO, and holds a Master's in Biopharmaceutical Sciences from Leiden University.

Contact· self-published, not guessed

f•••@gildehealthcare.comreveal

Invests in

BiotechDigital HealthMedical Devices

Experience

Gilde HealthcareGeneral Partner, Directorcurrent2020 — presentUtrecht, the Netherlands
Gilde HealthcareInvestment Director, Partner2006 — 2019
Gilde HealthcareInvestment Manager2004 — 2006
Gilde HealthcareAssociate2001 — 2004
SynOx TherapeuticsBoard membercurrent2025 — presentDublin, County Dublin, Ierland
SpliceBioBoard Membercurrent2022 — presentBarcelona, Catalonië, Spanje
Noema PharmaBoard Membercurrent2020 — present
LEVICEPT LTDBoard Membercurrent2014 — presentDiscovery Park, Sandwhich, Kent, UK
MoximedBoard Membercurrent2011 — presentHayward, California
Purespring TherapeuticsPast Board member2024 — 2025
Calypso BiotechPast Board Member2018 — 2024Geneva, Switzerland
Breath Therapeutics, a Zambon companyPast Board Member2017 — 2019Munich Area, Germany
SymphogenPast Board Observer2011 — 2018Pederstrupvej 93, 2750 Ballerup, Denmark
STAT-DxPast Board Member2016 — 2018Barcelona, Catalonia, Spain
ProQR TherapeuticsPast Board Member2014Leiden, the Netherlands
mtm LaboratoriesPast Board Member2009 — 2011Heidelberg, Germany
FlowCardiaPast Board Member2008 — 2010Sunnyvale, California, Verenigde Staten

Skills & more

Venture Capital32Venture Financing7Private Equity10Corporate Development14Growth Capital7Hardware Diagnostics2Orthopedic4M&A experienceLifesciences1Deal SourcingHealthcare14Deal Execution

+12 more

Capital RaisingBiotechnologyIPOPrivate PlacementsCancerMergersRestructuringMergers & AcquisitionsStrategyLife SciencesStart-upsBusiness Strategy

From Arthur's professional profile.

Colleagues at Gilde Healthcare

Besmire Ahmati

Senior Associate Investor Relations & Fundraising at Gilde Healthcare

Christiaan Sap

Operational Partner at Gilde Healthcare

Dirkjan Beugelsdijk

CFO at Gilde Healthcare

Edward Hanlon

Investment Director Venture&Growth at Gilde Healthcare

Edwin de Graaf

Managing Partner at Gilde Healthcare

Geoff Pardo

General Partner at Gilde Healthcare

Giel Modderman

Associate, Private Equity at Gilde Healthcare

Hugo de Bruin

General Partner at Gilde Healthcare

Frequently asked questions

Who is Arthur Franken?: Arthur Franken joined Gilde Healthcare in 2001 and helped launch the Venture&Growth strategy, overseeing investments in biopharmaceuticals, medtech, diagnostics, and digital health. He was previously a Research Fellow at the Leiden/Amsterdam Centre for Drug Research and TNO, and holds a Master's in Biopharmaceutical Sciences from Leiden University.
Where does Arthur Franken work?: Arthur Franken is General Partner - Healthtech/Therapeutics Venture&Growth at Gilde Healthcare.
What does Arthur Franken invest in?: Arthur Franken invests in Biotech, Digital Health, Medical Devices.
Where did Arthur Franken go to school?: Arthur Franken studied at Leiden University (MSc, Biopharmaceutical Sciences); Lingecollege (VWO-B).